Navis Capital Partners has sold its controlling stake in Malaysian IT firm Strateq to a local subsidiary of Singapore telecommunications company StarHub.
The Singaporean company announced the development in a filing. Navis said a StarHub subsidiary has agreed to acquire its interest in Strateq for MYR137 million ($32.5 million). Navis stands to earn a further...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.